You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic idiopathic myelofibrosis (cIMF)

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

IBD Trial in Mansoura (Metformin)

Recruiting
  • Inflammatory Bowel Diseases
  • Mansoura, Egypt
    Faculty of Medicine, Mansoura University
Nov 2, 2022

Myelofibrosis Trial in Hong Kong (Bomedemstat)

Recruiting
  • Myelofibrosis
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Oct 3, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Hyperbaric oxygen
  • Rochester, New York
    Wilmot Cancer Institute, University of Rochester
May 16, 2022

Myelofibrosis Trial in Houston (CK0804)

Not yet recruiting
  • Myelofibrosis
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jun 28, 2022

Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

The Nociceptive Flexion Reflex asDiagnostic Tool of Central

Recruiting
  • Central Sensitisation
  • +4 more
    • Ghent, Belgium
      Ghent University
    Nov 30, 2022

    Pelvic Pain Syndrome Trial in Kafr Ash Shaykh (Percutaneous Posterior Tibial Nerve Stimulation, Placebo Percutaneous Posterior

    Active, not recruiting
    • Pelvic Pain Syndrome
    • Percutaneous Posterior Tibial Nerve Stimulation
    • +2 more
    • Kafr Ash Shaykh, Egypt
      Kafrelshaikh University
    Oct 8, 2023

    Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)

    Recruiting
    • Idiopathic Pulmonary Hemosiderosis
    • Leflunomide
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Jun 30, 2023

    IBD Trial (Atorvastatin 80mg)

    Not yet recruiting
    • Inflammatory Bowel Diseases
    • Atorvastatin 80mg
    • (no location specified)
    Oct 14, 2022

    Healthcare Resource Utilization in Adult Myelofibrosis Through

    Recruiting
    • Myelofibrosis
      • La Plata, Buenos Aires, Argentina
      • +62 more
      Feb 1, 2023

      Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

      Recruiting
      • Myelofibrosis
      • +3 more
      • Birmingham, Alabama
      • +13 more
      Jan 10, 2023

      Constipation Trial in Manassas (ISOThrive Prebiotic Nectar)

      Completed
      • Constipation
      • ISOThrive Prebiotic Nectar
      • Manassas, Virginia
        ISOThrive Inc.
      May 4, 2022

      Myelofibrosis Trial in Jinan (Ruxolitinib)

      Recruiting
      • Myelofibrosis
      • Jinan, Shandong, China
        Qilu Hospital of Shandong University
      Jul 3, 2022

      Real World Evidence of Fedratinib Effectiveness in MF

      Not yet recruiting
      • Primary Myelofibrosis
      • +2 more
      • (no location specified)
      May 22, 2023

      Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

      Active, not recruiting
      • Primary Myelofibrosis
      • Secondary Myelofibrosis
      • Laboratory Biomarker Analysis
      • +2 more
      • Scottsdale, Arizona
        Mayo Clinic in Arizona
      Jan 7, 2022

      Juvenile Arthritis, Cardiorespiratory Fitness, Quality of Life Trial in Al-Kharj (Pilates exercises, Conventional physical

      Completed
      • Juvenile Arthritis
      • +2 more
      • Pilates exercises
      • Conventional physical therapy program
      • Al-Kharj, Riyadh, Saudi Arabia
        Outpatient Clinic of College of Applied Medical Sciences, Prince
      Mar 26, 2022

      Myelofibrosis Trial in Gilbert, Houston (APG-1252, Ruxolitinib)

      Withdrawn
      • Myelofibrosis
      • Gilbert, Arizona
      • +1 more
      Jul 8, 2022

      Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

      Suspended
      • Myelofibrosis
      • Adelaide, South Australia, Australia
      • +37 more
      Aug 18, 2022

      IBD Trial (Pentoxifylline 400 MG)

      Not yet recruiting
      • Inflammatory Bowel Diseases
      • Pentoxifylline 400 MG
      • (no location specified)
      Oct 28, 2022

      Affecting Factors in Juvenile Idiopathic Arthritis

      Recruiting
      • Arthritis, Juvenile Rheumatoid
      • +2 more
        • Istanbul, Fatih, Turkey
          Istanbul University
        Aug 17, 2023

        Johns Hopkins Crohn's Disease and Ulcerative Colitis Study

        Active, not recruiting
        • Inflammatory Bowel Disease
          • Baltimore, Maryland
            Johns Hopkins University
          Dec 6, 2022

          Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

          Recruiting
          • Myelofibrosis
          • +3 more
          • Birmingham, Alabama
          • +148 more
          Oct 10, 2022

          Chest Pain Trial (Mindfulness-Based Intervention)

          Not yet recruiting
          • Chest Pain
          • Mindfulness-Based Intervention
          • (no location specified)
          Jun 30, 2023

          Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

          Recruiting
          • Myelofibrosis
          • La Jolla, California
          • +165 more
          Aug 19, 2022

          Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)

          Recruiting
          • Primary Myelofibrosis
          • Secondary Myelofibrosis
          • Greifswald, Germany
          • +1 more
          Jun 15, 2022